Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 21 results for "wockhardt"

CDSCO puts Wockhardt, two others under scanner for selling drug without clearances
Money Control

CDSCO puts Wockhardt, two others under scanner for selling dru...

The CDSCO looks to give show case notices along with cancelling their licenses for the offence. These companies were apparently selling combination drugs to treat diabetes and fungal infections without the required approval. Money Control, 2 days ago

19 images for wockhardt

Money Control, 2 days ago
Business Standard, 1 month ago, 1 month ago, 1 month ago
Business Standard, 1 month ago
Business Standard, 1 month ago
Money Control, 2 months ago
Business Standard, 2 months ago
Money Control, 2 months ago
Money Control, 4 months ago
Business Standard

Wockhardt slumps after reporting loss in Q3

after the company reported consolidated loss of Rs 41 crore in Q3 December 2017, compared with loss of Rs 54 crore in Q3 December 2016. The announcement was made after market hours yesterday, 29 January 2018. Meanwhile, the S BSE Sensex was down 224.91 ...
 Business Standard1 month ago Wockhardt reports consolidated net loss of Rs 42.55 crore in the December 2017 quarter  Business Standard1 month ago Wockhardt reports standalone net loss of Rs 27.52 crore in the December 2017 quarter  Business Standard1 month ago
Business Standard

Indian pharma firms renew focus; Dr Reddy's, Cipla eye $100-bn China market

DRL looking to introduce anti-cancer drugs, while Cipla, Wockhardt planning to launch core therapies Aneesh Phadnis & Sohini Das | Mumbai/Ahmedabad Last Updated at February 14, 2018 01:30 IST Dr Reddy’s Laboratories (DRL) is expanding its presence in ...
 Business Standard1 month ago

David vs Goliath: How Wockhardt plans to beat global challenge

'While others went for big research business for diabetes and cancer, we went to antibiotics because big-pharma had vacated that space since the 80s.' Illustration: Uttam Ghosh/ Indian pharma is in a transformative phase following the pricing pressure on generic drugs in its key market, the US. While most firms are making a transition to less competitive complex generics and speciality drugs, Wockhardt is going beyond with its novel-drugs pipeline of five antibiotics. Habil ...
 Rediff.com1 month ago

Investors cheer Wockhardt on revival hopes; stock gained 41% in 2017

The drugmaker lost over Rs 20 billion of sales from the US market over the past four years
 Business Standard2 months ago
Money Control

Closing bell: Sensex, Nifty close flat amid volatility; Wockhardt most active

Reliance Nippon, Pidilite Industries, PVR, Ajanta Pharma, Reliance Communications, Monnet Ispat, Gokaldas Exports, Videocon Industries, Wockhardt and Unitech rallied 1-6 percent while Bank of India and Motherson Sumi were down 1 percent each.
 Money Control2 months ago Market Live: Sensex rebounds, Nifty opens above 10,450; Hero Moto, Hindalco lead  Money Control2 months ago
Money Control

Market Update: Wockhardt jumps 5%, hits new 52-week high; Hindalco, Sun Pharma top gainers, Maruti most active

The market breadth was in favour of the advances on Thursday morning with 1132 stocks advancing as against 423 declines while 422 remained unchanged. On the other hand, 1393 stocks advanced and 534 stocks declined while 72 remained unchanged on the BSE.
 Money Control2 months ago Market Update: IFCI zooms 24%; LT, HCL Tech top Nifty gainers, Sun TV at 52-week high, MM falls 3%  Money Control2 months ago
Business Standard

Wockhardt, Sun TV, KNR Constructions among 36 stocks hit 52-week highs

Varun Beverages, Motilal Oswal Financial Services, Sun TV Network, Eveready Industries, Future Consumer, Minda Industries were too hit 52-week highs in intra-day trade today. SI Reporter | Mumbai Last Updated at December 21, 2017 14:22 IST Wockhardt, Biocon, ...
 Business Standard2 months ago

Wockhardt jumps 11% after company offers Waluj facility for US FDA inspection

Wockhardt jumped over 9 percent intraday on Thursday hitting a new 52-week high of Rs 882 per share after the company said that it will be offering its Waluj facility near Aurangabad, Maharashtra in early 2018 for US FDA inspection.
 Money Control2 months ago

Stocks 360: Here#39;s why Wockhardt is in focus

Watch CNBC-TV18#39;s Ekta Batra give a 360 degree roundup on Wockhardt.
 Money Control1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less